December 8, 2021

More than US$27 billion committed to tackle global malnutrition and hunger crisis at the Tokyo Nutrition for Growth Summit

45 low- and middle-income countries led with strong policy and financial commitments

TOKYO, Dec. 08, 2021 (GLOBE NEWSWIRE) — Government and private sector donors have pledged more than US$27billion at the Tokyo Nutrition for Growth (N4G) Summit this week to address the global malnutrition and hunger crisis. Represented by five Heads of State and Government, 45 countries with high burdens of malnutrition and a dozen donors delivered renewed policy and financial commitments to end malnutrition. These commitments demonstrate country leadership and prioritization of nutrition at a crucial time, as fiscal resources are constrained and malnutrition rates are on the rise due to the continuing global COVID-19 pandemic.

“More than 140 million children suffer from stunting, and undernutrition is considered as an underlying cause of nearly half of deaths of children under five years old. Moreover, COVID-19 cast a significant impact on nutrition. The pandemic will likely cause 13.6 million more children to suffer from wasting,” said Japan’s Prime Minister, Fumio Kishida. “Let me recall our Sustainable Development Goal to end hunger, achieve food security and improve nutrition, and promote sustainable agriculture by 2030. Now is the time for us to take action. No one should be left behind.”

At the event, Japan committed over US$2.8 billion to provide nutrition-related assistance globally. Among other priorities, this investment will contribute to the achievement of nutrition in Universal Health Coverage and efforts to create more sustainable and nutritious food systems.

In addition to the donor’s pledge, countries with high burdens of malnutrition led the way at the Summit, delivering pledges towards increased domestic programming, as well as promising stronger policies and programs to reduce malnutrition rates. For example, Bangladesh, represented by Prime Minister Sheikh Hasina, committed to cut anemia rates by one-third, stunting among children by one-fifth, and wasting among children by one-quarter within the next five years.

The Government of Indonesia committed to fight malnutrition, and specifically to accelerate efforts to reduce stunting nationwide. Resources will support maternal and child nutrition interventions, including promotion of infant and young child feeding, nutritional supplementation for adolescent girls and pregnant women, and nutrition care and support for children with severe malnutrition.

Despite malnutrition being the underlying cause of nearly half of all child deaths under five, less than 1% of global foreign aid is currently spent on nutrition. To help close the gap, numerous donor governments and multi-lateral institutions also pledged a combined total of over US$27 billion in commitments at the Summit. The European Union committed US$2.8 billion over a three-year period, the United States committed US$11 billion over a three-year period, and the African Development Bank committed US$1.35 billion over a six-year period.

The 2015 Global Nutrition Investment Framework, led by the World Bank and Results for Development, identified a nutrition financing gap of more than US$700 billion dollars over 10 years to deliver evidence-based interventions that are largely delivered through the health sector. While the Summit’s commitments represent a significant step forward, they are still nowhere near what is necessary to end malnutrition.

UN agencies also delivered renewed commitments at the Summit. By 2025, UNICEF aims to reach at least 500 million children, adolescents and women annually with malnutrition prevention programs for the prevention of stunting, wasting, micronutrient deficiencies, overweight and obesity. The World Health Organization (WHO) committed to developing a Global Action Plan to prevent and manage anemia in women and children and to accelerate progress toward reducing anemia in women of reproductive age by 50% by 2030. The World Food Programme committed to increase the proportion of its programs’ beneficiaries who consume healthy diets from 40% in 2020 to 80% in 2025.

In addition, 44 civil society organizations from 26 countries delivered a range of financial and programmatic commitments, primarily aimed at reducing rates of undernutrition in vulnerable populations through improved nutritional care services, improved diets, and stronger social protection services. These stakeholders committed to investing approximately US$1 billion in priority interventions.

More than a dozen private sector companies made pledges at the event, including food companies promising to improve the nutritional quality of their products, contributing to more sustainable food systems, and improving the quality of their employees’ diets. Non-food businesses committed to supporting improved agricultural practices and the quality of their workforce’s diets by providing healthy and sustainable meals and joining relevant global alliances.

Even before COVID-19, the global burden of malnutrition remained worryingly high, though progress was being made in reducing the more severe forms of malnutrition, including stunting and wasting in early childhood. Malnutrition triggered by COVID-19 could kill 283,000 more children aged under-5, leave 13.6 million more wasted and 3.6 million more stunted, and make 4.8 million more women anemic over the next three years.

The Nutrition for Growth Summit—held on 7^th and 8^th December—focused on improving nutrition outcomes through universal health coverage, food systems transformation, and greater resilience in fragile and conflict-affected states. The Summit also emphasized financing and strong data systems as essential to strengthening program design, delivery, and accountability. The Summit is the culmination of the Nutrition for Growth Year of Action—a global effort to bring together country governments, donors, businesses, and UN agencies to accelerate progress on malnutrition.

During the closing session of the Tokyo Summit, French Minister for Europe and Foreign Affairs, Jean-Yves Le Drian, delivered France’s commitment to host the next Nutrition for Growth Summit linked to the Paris Olympic Games in 2024. The next Summit will be an opportunity to review progress and accountability for commitments delivered this week—and to deliver new commitments to combat malnutrition in the final five years of the Sustainable Development Goals.

# # #

Notes to Editors

The Nutrition for Growth Compact and an Annex of commitments is available online.

The first Nutrition for Growth Summit, hosted by the UK Government in London in 2013, and linked to the London Olympic Games, secured commitments of over US$4 billion to tackle undernutrition, and US$19 billion in complementary nutrition-sensitive investments between 2013 and 2020.

Global nutrition donors have all largely delivered on their previous Nutrition for Growth financial commitments, some several years early. According to the 2018 Global Nutrition Report, 10 of the 2013 signatories pledged a collective US$19.6 billion by 2020. The same 10 donors (US, EU, UK, the Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation, World Bank, Netherlands, Ireland, Germany, and Australia) cumulatively disbursed US$21.8 billion ahead of the 2020 goal.

Media Contacts:

UNICEF: Helen Wylie | hwylie@unicef.org | +19172442215

WHO: Pippa Haughton | haughtonp@who.int | +41794466331

WFP: Ljubica Vujadinovic | ljubica.vujadinovic@wfp.org | +393890009052

This content was issued through the press release distribution service at Newswire.com.

December 8, 2021

MegaFans Finds Traction, Milestone, Distributing NFTs and Cryptos for eSports

MegaFans Beats Break-even Model for Profitable Return on Ad Spend

MegaFans NFT

SAN DIEGO, Dec. 08, 2021 (GLOBE NEWSWIRE) — MegaFans, a mobile gaming company headquartered in Southern California, announced that they gained significant traction by distributing NFTs (non fungible tokens) and cryptocurrencies, as prizes to players on their mobile eSports platform. The company saw a large spike with in-app-purchases (IAPs) in November, surpassing their break-even goal for the return on advertising spend (ROAS) and established a sustainable and scalable business model.

“This is a huge milestone for MegaFans,” says CEO, Jeff Donnelley. “We achieved our goal to surpass break-even economics against ROAS, which makes this a sustainable business model, and we found traction using blockchain solutions and crypto products for our global audience. We couldn’t be happier with the results.”

MegaFans’ business model has multiple revenue streams including IAPs, a proprietary ad server, white label, tournament rake, sponsorship opportunities and more. They are in the early stages of optimization for their minimum viable product with play-to-earn tournament strategies, affiliate advertising, game development, gamfi, and tokenconomics still available to accelerate the business forward in 2022.

MegaFans offers free-to-play and play-to-earn options ranging from quick-play contests to monthly tournaments with larger prize pools up to $10,000 (USD). The pools scale up as community participation grows and players win virtual tokens that can be exchanged for other cryptocurrencies, NFTs, gift cards, or cash. The NFTs are distributed on OpenSea.io using the Polygon.technology chain to reduce gas fees.

MegaFans recently closed their seed round for funding, led by Alphabit and opened a private round, looking for partnerships to grow their platform and audience further. MegaFans is part of the Launchpool Labs incubator program where they are receiving strategic and technical support to help grow their community of gamers and collectors. Launchpool Labs incubator is a 90-day intensive development program focused on building communities and value around startups in the blockchain sector.

About MegaFans

MegaFans (Mobile eSports Gaming Fanatics) is building the world’s first mobile eSports community using blockchain, cryptocurrency, and NFTs in a play-to-earn environment for gamers and collectors, where 2.8 billion daily active users play, compete, and win prizes. MegaFans offers turnkey solutions for mobile game publishers and developers that increase monetization and retention by enriching the players experience. MegaFans mantra is “eSports for All!” which focuses on underserved markets around the world. They use a leaderboard format that features multiple tournaments simultaneously, to an infinite number of players globally, no matter what skill level or geo-location. Links to MegaFans social media and company channels can be found at https://linktr.ee/megafans.

Contact

Alexis Vera
MegaFans, Inc.
Phone: +1 (760) 889-3187
Email: PR@Megafans.com

Related Images

Image 1: MegaFans NFT

MegaFans NFT can be won playing Candy Boo eSports Game on Apple and Android phones and tablets.

This content was issued through the press release distribution service at Newswire.com.

Attachment

MegaFans NFT

December 8, 2021

Philips receives FDA 510(k) clearance for its most advanced acute patient monitors

December 08, 2021

Philips Patient Monitors IntelliVue MX750 and IntelliVue MX850 pair with advanced software and services to offer clinical decision support, continuous, scalable patient management and enhanced infection control

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its Philips Patient Monitors MX750 and MX850 have received 510(k) clearance from the U.S. Food and Drug Administration. Initially cleared for Emergency Use Authorization in 2020, the MX750 and MX850 are Philips’ most advanced patient monitors uniquely designed to support scalability, alarm management, cybersecurity and enhanced infection prevention within the hospital.

As health systems navigate the digital transformation, patient management solutions that can scale to meet hospital needs are in high demand. The MX750 and MX850 patient monitors are an integrated part of the company’s future-focused acute patient management solution, enabling hospitals to standardize at a system level and customize the solution in a particular care setting, even virtual or decentralized, to help optimize patient care. The monitors provide full modularity and are interoperable with other devices and applications, including Philips Patient Information Center iX and IntelliVue XDS software, to display critical patient data remotely or at the point of care.

“Continuous patient monitoring plays a vital role in overall patient safety while providing clinicians and caregivers with the holistic view they need to best support their patients and manage their workload,” said Sandra Lesenfants, General Manager, Hospital Patient Monitoring, Philips. “Philips Patient Monitors IntelliVue MX750 and MX850 are our most advanced patient monitors and a key part of our modular portfolio of hardware, software, services and consumables that can be tailored to provide integrated monitoring solutions that meet the individual needs of each healthcare provider.”

Data can also flow seamlessly between the MX750 and MX850 patient monitors and Philips Acute Care Telehealth command center to help to simplify clinical workflow with advanced clinical decision support, helping care teams better manage patient care across the continuum. The integrated system securely feeds patient data to a hospital’s electronic medical records via continuous, best in class, end-to-end encryption, meeting the industry’s evolving cybersecurity needs. The approach allows for virtually gap-free patient records from admission to discharge, even during transport, and connects care from the ICU to general ward, and across care settings.

This FDA 510(k) clearance allows Philips’ customers to expand their acute care and monitoring capabilities in the USA with the same MX750 and MX850 technology that has proven successful in hospitals across Europe since receiving CE mark in 2019.

“In the ICU, conditions can change quickly, so having access to real-time data is important to ensure signs of deterioration are not missed,” said Remko van den Akker, Registered Nurse, intensive care/critical care unit, Adrz Hospital, The Netherlands. “Philips’ solutions have helped us to improve the link between essential patient data and our hospital patient data management system, and allow us to automatically and securely share data. This level of interoperability has been key for successfully managing our acute care patients.”

Philips MX750 and MX850 patient monitors also feature a rugged design that can withstand the strongest hospital-grade disinfectants to help minimize hospital acquired infections without degrading the device. This helps caregivers to increase efficiency, while ensuring high quality patient care.

To learn more about Philips’ patient monitors, please visit our resource page on future focused monitoring.

For further information, please contact:

Anna Hogrebe
Philips Global Press Office
Tel: +1 416 270 67 57
E-mail: anna.hogrebe@philips.com

Meredith Amoroso
Philips Global Press Office
Tel: +1 724-584-8991
E-mail: meredith.amoroso@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

December 8, 2021

Lantronix ได้รับเลือกเป็นสมาชิกของ Qualcomm Automotive Solutions Ecosystem Program

Lantronix เป็นสมาชิกของ Qualcomm Advantage Network มาอย่างยาวนาน และเข้าร่วมโครงการเฉพาะผู้ได้รับเชิญเพื่อช่วยเร่งสร้างนวัตกรรมยานยนต์

เออร์ไวน์ แคลิฟอร์เนีย , Dec. 08, 2021 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX) ผู้ให้บริการระดับโลกด้านโซลูชั่นแบบเบ็ดเสร็จที่ปลอดภัยในด้าน Intelligent IT และ Internet of Things (IoT) ประกาศในวันนี้ว่า บริษัทได้รับเลือกให้เป็นสมาชิกของ Qualcomm^®ซึ่งเป็นโครงการยานยนต์ของ Authorized Design Center Program Lantronix ซึ่งเป็นสมาชิกของ Qualcomm^® Advantage Network มาเป็นเวลานาน ได้เข้าร่วมโครงการเฉพาะผู้ได้รับเชิญ ซึ่งช่วยบริษัทต่าง ๆ ในการเร่งสร้างนวัตกรรมโดยเชื่อมโยงลูกค้ากับระบบนิเวศของธุรกิจที่มีเครื่องมือและบริการออกแบบอย่างเชี่ยวชาญได้อย่างลึกซึ้ง Lantronix จะเข้าร่วมในโครงการยานยนต์ที่เรียกว่าโครงการ Qualcomm^® Automotive Solutions Ecosystem โดยให้การเข้าถึงเครื่องมือที่สร้างขึ้นโดยเน้นแนวคิดของแพลตฟอร์มห้องนักบินยานยนต์ Snapdragon^® รุ่นที่ 3 (the 3^rd Generation Snapdragon^® Automotive Cockpit Platform) ซึ่งเป็นผลิตภัณฑ์ของ Qualcomm Technologies, Inc.

“เราภูมิใจที่ได้รับการเสนอชื่อให้เป็นสมาชิกของโครงการ Automotive Solutions Ecosystem ของ Qualcomm Authorized Design Center ซึ่งจะนำความเชี่ยวชาญด้านวิศวกรรมและการออกแบบมาสู่ลูกค้าร่วมกันของเรา และในขณะเดียวกันก็ช่วยเหลือด้านนวัตกรรมอย่างรวดเร็ว” Paul Pickle ซีอีโอของ Lantronix กล่าว “ด้วยโครงการนี้ Lantronix จะอยู่ในตำแหน่งที่สามารถเร่งการจำหน่ายผลิตภัณฑ์ยานยนต์ ซึ่งรวมถึงการปรับแต่ง การเพิ่มประสิทธิภาพ และบริการออกแบบและบูรณาการอื่น ๆ ที่สร้างขึ้นโดยเน้นแนวคิดของแพลตฟอร์มห้องนักบินยานยนต์ Snapdragon รุ่นที่ 3 (the 3^rd Generation Snapdragon Automotive Cockpit Platforms)”

แพลตฟอร์มห้องบังคับยานยนต์ Snapdragon รุ่นที่ 3 (The 3^rd Generation Snapdragon Automotive Cockpit Platforms) นั้นใช้ปัญญาประดิษฐ์ (AI) และแพลตฟอร์มยานยนต์ที่ล้ำหน้าที่สุดบางส่วนจาก Qualcomm Technologies โดยได้รับการออกแบบมาเพื่อรองรับห้องนักบินแบบบูรณาการที่อุดมด้วยซอฟต์แวร์ ซึ่งได้รับการออกแบบทางวิศวกรรมให้ตรงตามมาตรฐานอุตสาหกรรมยานยนต์ที่เข้มงวด แพลตฟอร์มห้องนักบินยานยนต์ Snapdragon รุ่นที่ 3 (The 3^rd Generation Snapdragon Automotive Cockpit Platforms) นี้ได้รับการออกแบบทางวิศวกรรมด้วยกราฟิกที่สมจริง มัลติมีเดีย คอมพิวเตอร์วิทัศน์ และความสามารถด้าน AI ขั้นสูง แพลตฟอร์มห้องบังคับยานยนต์ Snapdragon ยังมอบสถาปัตยกรรมที่ปรับขนาดได้อย่างเต็มที่พร้อมประสบการณ์ที่แตกต่าง โดยใช้สถาปัตยกรรมซอฟต์แวร์และเฟรมเวิร์กเดียวกัน เพื่อให้ผู้บริโภคเพลิดเพลินไปกับประสบการณ์ผู้ใช้ที่กลมกลืนกันโดยไม่ขึ้นกับระดับของยานพาหนะในขณะที่ใช้เฟรมเวิร์กซอฟต์แวร์เดียวกัน

การรวม Lantronix ไว้ในโปรแกรม Qualcomm Automotive Solutions Ecosystem รวมถึงความเชี่ยวชาญและความร่วมมือที่ได้รับการพิสูจน์แล้วจากทีมในช่วงหลายปีที่ผ่านมานั้น ได้ตอกย้ำถึงความมุ่งมั่นในการให้บริการด้านการพัฒนาที่ล้ำสมัยด้วย Qualcomm Technologies สำหรับลูกค้าทั่วโลกที่เน้นไปที่แพลตฟอร์มห้องนักบินยานยนต์ Snapdragon

เกี่ยวกับ Lantronix

Lantronix Inc. เป็นผู้ให้บริการโซลูชันแบบครบวงจรที่ปลอดภัยด้าน Internet of Things (IoT) และ Remote Environment Management (REM) ที่นำเสนอ Software as a Service (SaaS) บริการเชื่อมต่อ บริการวิศวกรรม และฮาร์ดแวร์อัจฉริยะ

Lantronix ช่วยให้ลูกค้าเร่งเวลาออกสู่ตลาดและเพิ่มเวลาทำงานและประสิทธิภาพด้วยการจัดหาโซลูชั่น Intelligent Edge IoT และ Remote Management Gateway ที่เชื่อถือได้ มีความปลอดภัยและเชื่อมโยงกัน

ผลิตภัณฑ์และบริการของ Lantronix ช่วยลดความยุ่งยากในการสร้าง พัฒนา ใช้งาน และจัดการโครงการ IoT และ IT ได้อย่างมาก ทั้งในส่วนของ วิทยาการหุ่นยนต์ ยานยนต์ อุปกรณ์สวมใส่ การประชุมทางวิดีโอ อุตสาหกรรม การแพทย์ โลจิสติกส์ เมืองอัจฉริยะ ความปลอดภัย การค้าปลีก สำนักงานสาขา ห้องเซิร์ฟเวอร์ และแอปพลิเคชันศูนย์ข้อมูล ดูรายละเอียดเพิ่มเติมได้ที่ เว็บไซต์ Lantronix.

โปรดดูรายละเอียดเพิ่มเติมได้ที่ บล็อก Lantronixซึ่งมีการอภิปรายและการอัปเดตทางอุตสาหกรรม ติดตาม Lantronix บน ทวิตเตอร์ ดู ห้องสมุดวิดีโอ YouTubeของเรา หรือติดต่อเราได้ที่ LinkedIn

คำชี้แจง “Safe Harbor” ภายใต้พระราชบัญญัติปฏิรูปการฟ้องร้องคดีหลักทรัพย์เอกชนปี 1995: ข้อความใด ๆ ที่ระบุไว้ในข่าวประชาสัมพันธ์ฉบับนี้ซึ่งไม่ใช่ข้อมูลทางประวัติศาสตร์และข้อเท็จจริงทั้งหมด ซึ่งรวมถึงแต่ไม่จำกัดเพียงข้อความที่เกี่ยวข้องกับโซลูชัน เทคโนโลยี และผลิตภัณฑ์ของเรา ข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตนี้อ้างอิงจากการคาดการณ์ในปัจจุบันของเราและอาจอยู่ภายใต้ความเสี่ยงและความไม่แน่นอนที่อาจก่อให้เกิดผลประกอบการที่แท้จริงของเรา ธุรกิจในอนาคต สถานะทางการเงินหรือผลการดำเนินงานที่แตกต่างอย่างมากจากผลประกอบการในอดีตของเรา คำสั่งที่มีอยู่ในข่าวประชาสัมพันธ์นี้หรือที่กล่าวโดยชัดแจ้งหรือโดยนัยในข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตใด ๆ ที่ปรากฏอยู่ในข่าวเผยแพร่นี้ ความเสี่ยงและความไม่แน่นอนที่อาจเกิดขึ้นได้ รวมถึงแต่ไม่จำกัดเพียงปัจจัยต่าง ๆ เช่น ผลกระทบจากสภาวะทางเศรษฐกิจในภูมิภาคและทั่วโลกที่ส่งผลกระทบในทางลบหรือแย่ลงหรือส่งผลกระทบต่อความไม่แน่นอนในตลาดในธุรกิจของเรา รวมถึงผลกระทบต่อการตัดสินใจซื้อของลูกค้าของเรา ผลกระทบของการแพร่ระบาดของโควิด-19 ต่อพนักงานของเรา ห่วงโซ่อุปทานและห่วงโซ่การกระจายสินค้า และเศรษฐกิจโลก ความเสี่ยงด้านการรักษาความปลอดภัยทางไซเบอร์ การเปลี่ยนแปลงกฎหมาย กฎระเบียบ และภาษีของรัฐบาลสหรัฐอเมริกาและกฎหมายต่างประเทศที่บังคับใช้ ความสามารถของเราในการใช้กลยุทธ์การเข้าซื้อกิจการของเราสำเร็จหรือรวม บริษัทที่ได้มา ความยุ่งยากและค่าใช้จ่ายในการคุ้มครองสิทธิบัตรและสิทธิในทรัพย์สินอื่นๆ ระดับของหนี้สินของเราความสามารถของเราในการให้บริการหนี้ของเราและข้อจำกัดในสัญญาหนี้ของเรา และปัจจัยเพิ่มเติมใดๆ ที่รวมอยู่ในรายงานประจำปีของเราในแบบฟอร์ม 10-K สำหรับปีงบการเงินสิ้นสุดวันที่ 30 มิถุนายน 2020 ซึ่งยื่นต่อสำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ (“SEC”) เมื่อวันที่ 11 กันยายน 2020 รวมถึงในหัวข้อ “ปัจจัยเสี่ยง” ในข้อ 1A ของส่วนที่ 1 ของรายงานดังกล่าวรวมถึงในเอกสารที่เรายื่นต่อสาธารณะอื่น ๆ กับ SEC อาจมีการระบุปัจจัยเสี่ยงเพิ่มเติมเป็นครั้งคราวในเอกสารที่เรายื่นในอนาคต ข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตที่รวมอยู่ในข่าวประชาสัมพันธ์ฉบับนี้จะกล่าวถึง ณ วันที่ในที่นี้ และเราไม่มีข้อผูกมัดใด ๆ ในการปรับปรุงข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตเหล่านี้เพื่อสะท้อนเหตุการณ์หรือสถานการณ์ที่ตามมา

Snapdragon Automotive Cockpit Platform เป็นผลิตภัณฑ์ของ Qualcomm Technologies, Inc. และ/หรือบริษัทในเครือ Qualcomm Authorized Design Center Program, Qualcomm Automotive Solutions Ecosystem Program, และ Qualcomm Advantage Network เป็นโปรแกรมของ Qualcomm Technologies, Inc. และ/หรือบริษัทในเครือ

Qualcomm และ Snapdragon เป็นเครื่องหมายการค้าหรือเครื่องหมายการค้าจดทะเบียนของ Qualcomm Incorporated

ติดต่อด้านสื่อ Lantronix:
Gail Kathryn Miller
ผู้จัดการฝ่ายการตลาดและการสื่อสารองค์กร
media@lantronix.com
949-453-7158

ข้อมูลติดต่อนักวิเคราะห์และนักลงทุน Lantronix:
Jeremy Whitaker
ประธานเจ้าหน้าที่ฝ่ายการเงิน
investors@lantronix.com
949-450-7241

ฝ่ายขายของ Lantronix:
sales@lantronix.com
อเมริกา +1 (800) 422-7055 (สหรัฐอเมริกาและแคนาดา) หรือ +1 949-453-3990
ยุโรป, ตะวันออกกลางและแอฟริกา +31 (0)76 52 36 744
ภูมิภาคเอเชียแปซิฟิก + 852 3428-2338
จีน + 86 21-6237-8868
ญี่ปุ่น +81 (0) 50-1354-6201
อินเดีย +91 994-551-2488

December 8, 2021

Proteona announces multiple ASH presentations highlighting novel gene signatures in hematological cancers identified using advanced single-cell biomarker discovery platform

Meet Proteona at ASH 2021

Proteona announced one oral presentation and two poster presentations at ASH 2021

SINGAPORE, Dec. 08, 2021 (GLOBE NEWSWIRE) — Proteona, a single-cell precision medicine company, today announced that three abstracts from the company and its collaborators have been accepted for presentation at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition to be held on December 11-14 in Atlanta, Georgia.

Two of the upcoming presentations, conducted in collaboration with Professor Chng Wee Joo (Director of the National University Cancer Institute, Singapore), identified novel biomarkers using Proteona’s ESCAPE™ and MapSuite™ platforms for single-cell multi-omic library generation and AI-assisted data analysis, respectively. In the first study on Acute Myeloid Leukemia (oral presentation #378), Proteona’s technology identified gene signatures from multiple dysregulated immune cell types that correlated with overall survival. In a second study on multiple myeloma (poster #2653), Proteona’s technology identified a gene signature in <1% of tumor microenvironment cells that correlated with progression-free survival in patients with the t(4:14) translocation.

In the third presentation (poster #2954), Proteona and its collaborators from Professor Limsoon Wong’s lab (National University of Singapore) will present MapBatch™, a novel machine-learning method for single-cell data batch correction that outperforms current approaches by retaining greater signal to noise.

“Alterations in the immune microenvironment play a key role in hematological cancer treatment response. Single-cell insights are critical to advance our understanding of how the microenvironment regulates response. Proteona’s technology platform and expertise in developing single-cell gene signatures helped us identify biological insights that we could not have generated ourselves,” said Professor Chng. “We are in the process of validating the gene signatures identified and are excited to collaborate with Proteona on future projects in hematological cancer.”

“These studies demonstrate the value of Proteona’s single-cell technology platform to generate valuable insights for our research partners,” said Dr Andreas Schmidt, CEO of Proteona. “We aim to advance precision medicine in hematological and other cancers by developing industry-leading solutions for single-cell biomarker discovery, validation, and clinical use.”

Presentations details:

Oral presentation #378: Single-Cell Multi-Omic Analysis Uncovers Comprised Immune Function and Primary Resistance Mechanism in Acute Myeloid Leukemia.
December 12, 10:45 AM ET
Thomas Murphy Ballroom 3-4

Poster #2653: Single Cell Multi-Omic Profiling of Multiple Myeloma with t(4;14) Finds an Immune Microenvironment Gene Signature That Correlates with Clinical Outcomes.
December 12, 6-8 PM ET
Hall B5

Poster #2954: Mapbatch: Conservative Batch Normalization for Single Cell RNA-Sequencing Data Enables Discovery of Rare Cell Populations in a Multiple Myeloma Cohort.
December 12, 6-8 PM ET
Hall B5

About Proteona

Proteona is a biomedical company in Singapore, Germany, and the US that is pioneering the use of single-cell proteogenomics to improve clinical outcomes in cancer. Using a combination of innovative single-cell assays and AI-assisted bioinformatics, Proteona provides a comprehensive sample-to-answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles. https://proteona.com/

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4136c9de-3172-49bf-8ee2-114bbc404a2e

For media queries, please contact info@proteona.com

December 8, 2021

Conagen’s Fermentation Technology To Support DARPA’s ReSource Sustainability Program

Bedford, Mass., Dec. 08, 2021 (GLOBE NEWSWIRE) — Massachusetts-based biotech Conagen announced its participation in a collaboration supporting the ReSource program funded by a U.S. Department of Defense (DOD) grant. The project aims to leverage Conagen’s proprietary fermentation technology to convert plastics and other energy-dense waste into valuable, reusable materials.

“Humanity needs to make better use of plastic resources and close the recycling loop,” said Casey Lippmeier, Ph.D., vice president of innovation at Conagen. This cooperative agreement project will demonstrate the value of recycled material for building a sustainable infrastructure.”

Under the DOD, the U.S. Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office created the ReSource Program to research and develop an integrated self-containment system. The project explores using a combination of synthetic biology and chemical technology for turning plastic waste into critical supplies.

Professor Chris A. Voigt, Ph.D., directs the project at the Massachusetts Institute of Technology (MIT) in collaboration with Conagen and Novoloop. The Voigt lab has expertise in microbial genetic design and engineering and has created tools and platform technologies central to the effort.

Conagen was selected as the fermentation scale-up partner for its synthetic biology expertise, purification process development capability, and world-scale manufacturing.

“While conventional fermentation has been used for centuries to make foods and beverages, precision fermentation has become the core resource for commercializing natural and sustainable synthetic biology products,” said Lippmeier.

Novoloop uses chemical technologies to decompose plastic waste into chemical building blocks, enabling the downstream fermentation to make bio-products.

“Recycling plastic waste is just the beginning,” says Lippmeier. “This DARPA-funded project primarily seeks to improve the efficient use of resources by our troops. However, the technology for converting plastics and bio-plastics into other higher-value materials should create incentives to remove these pollutants from the environment and support humanitarian efforts with renewable sources of food, nutrition, and water.”

Now that Phase I is complete, the MIT team, including Conagen, advance to Phase II when they
hope to achieve purifying, scaling, and upcycling waste into valuable products.
About Voigt Lab, MIT
Voigt Lab is focused on the development of a programming language for cells. A genetic program consists of a combination of genetic circuits, each of which uses biochemistry to replicate a function analogous to an electronic circuit (e.g., a logic gate) and applying these tools to problems in biotechnology http://web.mit.edu/voigtlab/.

About Conagen

Conagen is a product-focused synthetic biology R&D company with large-scale manufacturing capabilities. Our scientists and engineers use the latest synthetic biology tools to develop high-quality, sustainable, nature-based products by precision fermentation and enzymatic bioconversion. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. www.conagen.com

About Novoloop
Novoloop was founded in 2015 to deliver next-generation materials made from plastic waste via its patented low-carbon upcycling technology ATOD™. Through its proprietary dicarboxylic acid platform, hard-to-recycle plastic waste is transformed into virgin quality materials with superior sustainability at competitive pricing. With its first product, Oistre™, Novoloop provides sustainable and customizable thermoplastic polyurethane solutions for the footwear, sporting goods, and automotive sectors.

Distribution Statement “A”
Approved for Public Release, Distribution Unlimited. If you have any questions about DARPA, please contact the Public Release Center.

Attachment

Conagen collaborates with MIT and DARPA on ReSource Program

Ana Arakelian
Conagen
+1.781.271.1588
ana.arakelian@conagen.com

December 8, 2021

MRM Health Announces First Patient Dosed with Next Generation Live Microbiome Consortia Therapeutic MH002 in Phase 1b/2a Study in Patients with Ulcerative Colitis

GHENT, Belgium, Dec. 08, 2021 (GLOBE NEWSWIRE) — MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced that the first patient received MH002 in a phase 1b/2a multi-center clinical trial in mild-to-moderate Ulcerative Colitis. MH002 is MRM Health’s first clinical product candidate resulting from its proprietary and unique CORAL™ platform technology.

“We are very excited about this next step in the development of MH002 in Ulcerative Colitis,” said Sam Possemiers, Ph.D., Chief Executive Officer of MRM Health. “Treatment of the first patient in this study is a major achievement for our team, a milestone for the company, and an important step towards improving the lives of patients with Ulcerative Colitis (UC). We thank our Belgian and international investigators for their commitment in successfully advancing our first clinical program resulting from the CORAL™ platform.”

MRM Health’s MH002-UC-201 study is a multi-center, double-blind, randomized, placebo-controlled trial in multiple clinical sites in Belgium, Poland and Czech Republic and will enrol 45 mild-to-moderate UC patients. The trial will evaluate safety, mechanistic effects, and initial efficacy of MH002 on disease activity. More information about the trial is available at clinicaltrialsregister.eu, with identifier 2020-004355-33.

“My medical team is very motivated to study this promising novel treatment in our patients,” said investigator Prof. Pieter Dewint, (MD, PhD), Gastroenterologist at AZ Maria Middelares, Ghent, Belgium. “The potential to offer an effective treatment to our patients that is devoid of severe or serious risks would represent a true advancement for their well-being.”

“There is an important medical need for an effective and safe new medicinal product for the treatment of mild-to-moderate UC,” said Prof. Séverine Vermeire (MD, PhD), IBD expert at the Gastroenterology Department of the University Hospitals Leuven, Belgium, and principal investigator of the trial. “MH002 has all the characteristics and potential to fill that need and may become a novel tool in the first-line treatment of UC.”

MH002 is the first product candidate resulting from MRM Heath’s CORAL™ platform, in which key disease-driving mechanisms guide therapeutic microbial strain selection, to enter clinical studies in patients. Preclinical studies in inflammatory bowel disease (IBD) models showed that MH002 repairs gut microbiome dysbiosis, heals the dysfunctional intestinal barrier, and restores immune homeostasis with its differentiated mechanism targeting multiple key disease pathways. MH002 has demonstrated excellent safety and superior preclinical efficacy as compared to conventional, non-optimized microbiome therapeutics, as well as mesalamine, the current first-line standard of care in UC.

As part of the CORAL™ platform, MH002 is produced through a breakthrough scalable, robust, and standardized cGMP manufacturing technology, overcoming past microbiome challenges in manufacturing multi-strain consortia of uniform composition. CORAL™ allows the manufacturing of complete consortia as a single drug substance, expected to provide both key regulatory and patient compliance advantages.

About MRM Health

MRM Health NV, Ghent, Belgium, is a biopharmaceutical company focused on the development of next-generation optimized consortium therapeutics based on the human microbiome. The company has built a diversified pipeline with its proprietary CORAL™ platform to design, optimize, and manufacture bacterial consortia as single drug substance. Its most advanced program MH002 is an optimized consortium of 6 rationally-selected and well-characterized commensal strains. MH002 is entering a Phase 1b/2a study in patients with mild-to-moderate ulcerative colitis in Q4 2021. Additional pipeline development includes a preclinical program in Parkinson’s disease, two preclinical programs in metabolic disease (partnered with IFF Nutrition Biosciences, previously DuPont), and a discovery program in autoimmune disease, including spondyloarthritis.

About CORAL™

MRM Health’s differentiating CORAL™ platform utilizes a bioinformatics-guided in-human discovery engine combined with a breakthrough in optimization and manufacturing of consortia as single drug substance. The proprietary consortia optimization technology allows to develop next-generation consortia therapeutics with faster onset-of-action and increased potency and robustness. The breakthrough scalable, robust, and standardized cGMP-compliant consortia manufacturing technology allows to manufacture complete therapeutic consortia as a single drug substance in a single manufacturing process which strongly surpasses existing approaches in speed, reduced complexity, increased robustness and lower cost.

About IBD and UC

Ulcerative colitis (UC) is a chronic, autoimmune, inflammatory bowel disease (IBD) characterized by mucosal inflammation of the rectum and colon resulting in debilitating diarrhea, abdominal pain, and rectal bleeding. Current treatments include symptomatic anti-inflammatory therapies and immunosuppressants. In many cases, these therapies fail to induce enduring remission and/or cause potentially severe adverse events.

Substantial clinical unmet need persists in UC as many patients remain refractory to standard of care and current treatments (e.g., anti-inflammatory, immunosuppression approaches) primarily provide symptomatic relief. MH002’s disease-modifying mechanism is anticipated to induce remission via immunomodulation, rather than immunosuppression, resulting in superior safety with no elevated risks associated with reduced immune system functioning.

For further information please contact:

Dr Sam Possemiers – CEO
Christiane Verhaegen – CFO
Phone: +32.9.241.11.88
info@mrmhealth.com

December 8, 2021

Wholesale Fashion Industry Sees Strong Momentum in Digital Commerce for the Second Consecutive Year

End of year statistics from JOOR illustrate that online B2B shopping is the new normal; highlight the importance of small business and increasing APAC adoption

NEW YORK, Dec. 08, 2021 (GLOBE NEWSWIRE) — JOOR, the world’s leading digital wholesale platform, today released its end of year figures for 2021. These data points confirm the continued acceleration of digital adoption among brands and retailers, and that even with the return of in-person markets and events, electronic B2B commerce continues to play an important and ever increasing role in the fashion ecosystem.

In light of evolving supply chain uncertainty, the real-time insights delivered by the JOOR platform proved especially critical to both brands and retailers in 2021. The volume of wholesale transactions (GMV) passing through the JOOR platform increased 60% from 2020, averaging over $1.5bn per month. The number of orders placed on the platform increased 35% year over year, and the average order value (AOV) increased 59% over the prior year.

“We continue to see significant momentum in our business because we prioritize innovations that meaningfully impact the businesses of our brands and retailers,” explained Kristin Savilia, CEO of JOOR. “In 2022, we will look to build out successful offerings including a new and improved JOOR Marketplace to facilitate enhanced product discovery and our electronic payment and financing capabilities.”

Despite a spike in virtual buying and selling at the onset of the pandemic in early 2020, brand and retailer engagement on JOOR increased even further in 2021. 400,000 new connections between brands and retailers have been completed this year to date. Rich content served to enhance the connection experience, with brands uploading almost 85% more images to JOOR than they did in 2020.

Retailers were more active than ever on JOOR, particularly as it pertains to small and medium-sized businesses. As the pandemic recovery has progressed, consumers globally have increasingly chosen to shop local, as reported by Deloitte and others. JOOR’s retail accounts grew by 100,000—a 37% increase from 2020 to 2021, almost exclusively driven by boutique establishments joining the platform.

Ongoing uncertainty concerning public health combined with resolve to increase sustainability have led the industry to rethink the way it travels. Fashion weeks and market shows, once exclusively in-person, have evolved to hybrid events. Through its JOOR Passport platform, JOOR powered 36 events attracting more than 150,000 retail visitors from 150 countries. Over 2,400 brands participated in a JOOR Passport event and sold 215,000 products. All of these figures represent the upward trend from 2020 and provide clear validation for the hybrid model approach.

Following the announcement of its Shanghai office earlier this year, JOOR saw notable growth in China and Asia-Pacific. Brands based in this region of the globe accepted almost 50% more orders and sold over 80% more items in 2021 than in 2020. The Shanghai office bolstered JOOR’s footprint in the region to three offices total, including Tokyo and Melbourne. The ability to receive 24/7 customer support in local languages will allow Chinese brands and retailers to further accelerate their digital transformation in 2022.

JOOR’s complete 2021 End of Year Trend Report, highlighting 2021 data and the top industry trends that will shape wholesale in 2022, can be viewed by clicking here.

About JOOR
JOOR is the world’s leading wholesale management platform, with over $1.5Bn in wholesale transactions processed every month. More than 13,000 brands and over 360,000 curated fashion retailers across 150 countries connect on the platform every day. With a commitment to fueling the advancement and growth of both brands and retailers, JOOR provides a digital ecosystem that combines dynamic virtual showrooms with collaborative tools including JOOR Passport, which centralizes the trade show experience across multiple global fashion events. JOOR users have greater flexibility, visibility, performance and insights into their business. JOOR is the exclusive platform for leading luxury conglomerates including LVMH, Kering and Richemont, as well as brands such as Balenciaga, Valentino and Saint Laurent. JOOR has exclusive partnerships with 30+ leading global retailers using the JOOR Retail Partner platform including: Harrod’s, Neiman Marcus, Harvey Nichols, Printemps, Bergdorf Goodman, Shopbop, 24S.com, Revolve, FWD, Liberty London and Dover Street Market. JOOR is headquartered in New York City and has offices in Los Angeles, Philadelphia, Paris, London, Milan, Madrid, Berlin, Melbourne, Tokyo and Shanghai. For more information visit: JOOR.com.

Contact: Lindsey Huttrer
joor@nectarpr.com

December 8, 2021

Race for quality office assets in major cities spurred by ESG and limited supply – 2022 Global Investor Outlook reveals

Investing with intent becoming as clear a priority as financial performance

Colliers 2022 Global Investor Outlook

The 2022 Global Investor Outlook is Colliers’ in-depth exploration of investor sentiment, strategies, and the forces set to shape real estate markets around the world.

LONDON and TORONTO, Dec. 08, 2021 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company Colliers (NASDAQ and TSX: CIGI) reveals quality office assets in major metropolitan markets like London, New York, Tokyo, and Sydney have retained their allure and will be in high demand next year. Core and core-plus office spaces are the top global strategy picks, with 60% of investors stating these as their investment preference for 2022, a 50% increase from last year.

Their appeal not only stems from the realization that office demand is here to stay, particularly in cities supported by strong transport infrastructure and high amenity values, but also the ease of large-scale capital deployment that office assets represent. The rising cost of construction, viewed by 4 in 5 (81%) investors as a pain point, limiting new builds, renovations, and retrofit projects amplify the race to core. Investors expect core office values to increase by up to or more than 10% over the next 12 months due to the stark imbalance between demand and supply.

“Based on our 2022 Global Investor Outlook, pent-up demand and delayed transactions will translate into momentum next year. However, investors face an increasingly complex and competitive marketplace, coloured by new regulations and COVID-19 uncertainties. With the amount of dry powder readily available, offices in Tier 1 cities are seen as safe haven assets that offer an attractive route to deploy capital,” said Tony Horrell, Head of Global Capital Markets at Colliers.

Investing with intent

This year’s report shows ESG (environmental, social, governance) considerations are prominent, with nearly 3 in 4 investors integrating environmental factors into their strategies. This desire to invest with intent is both a means of future-proofing their assets and responding to stakeholder and societal pressures requiring them to respond to the climate crisis.

Sustainability is creating a greater chasm between newer, high-quality assets in prime space and older, second-hand stock in city submarkets. To protect their portfolios, investors are concentrating on Grade-A buildings that prioritize sustainability and wellness credentials, while disposing of aging, non-compliant assets that risk potential obsolescence if they are not regarded as retrofit opportunities to capitalize. This recalibration of assets under management will drive market turnover.

“COP26 has reinforced that the next 10 years are imperative to the future of our planet,” said Chris Pilgrim, Director of Global Capital Markets. “The pandemic, climate-related disruptions, and growing recognition of social inequality are prompting investors to adopt a more robust approach to sustainability-related risks. As the number of ESG regulatory requirements continue to soar, we expect investors will be rushing to sell potential stranded assets to avoid discounted prices later.”

Partnership key to realizing diversified portfolios

The pandemic introduced new risks and heightened others for certain real estate assets. Investors are looking for more ways to ensure their portfolios are resilient and diversified, exploring specialized assets such as data centres, life science facilities, affordable and student housing that benefit from their strong ties to demographic and societal trends.

“Joint ventures, local partnerships, and M&A strategies are great for savvy investors who want to get ahead. Alternative assets present compelling investment cases, but their unique characteristics make teaming up with the right partner essential. There is a clear need for expertise to fill knowledge gaps and safely guide capital, particularly those in nascent sectors,” said Damian Harrington, Head of Global Capital Markets Research.

Other key findings from the Colliers 2022 Global Investor Outlook include:

Logistics: Industrial and logistics assets are the most attractive asset class overall, with 69% of investors choosing this as the preferred sector globally, due to the surging demand for e-commerce.
Retail: Grocery-linked convenience assets are the most popular retail asset type, accounting for 60% of the retail vote globally, yet some segments of retail such as luxury high-street are making a comeback. Shopping centres are ripe for conversion to last-mile logistics or mixed-use assets, with 30-50% of investors expressing interest in opportunistic and value-add strategies.
Multifamily/build-to-rent: Investors’ optimism about the broad range of residential opportunities connected closely to economic and demographic trends is driving higher investment volumes in all markets in 2021. Multifamily is the third most popular sector, with 42% of investors expressed an interest in in 2022.

About the Colliers 2022 Global Investor Outlook

The second edition of our annual outlook for global property investors is based on a focused survey undertaken by 300+ investors across the globe and in-depth interviews with our regional Capital Markets leaders. The findings and opinions featured in the report are shaped by their responses.

About Colliers

With operations in 65 countries, our more than 15,000 enterprising professionals work collaboratively to provide expert advice to real estate occupiers, owners, and investors. For more than 26 years, our experienced leadership with significant insider ownership has delivered compound annual investment returns of almost 20% for shareholders. With annualized revenues of $3.6 billion ($4.0 billion including affiliates) and $46 billion of assets under management, we maximize the potential of property and accelerate the success of our clients and our people. Learn more at corporate.colliers.com, Twitter @Colliers or LinkedIn.

Media Contact

Andrea Cheung
Global Manager, Communications
Andrea.cheung@colliers.com
416-324-6402

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e04b6dab-b5ef-404f-8e65-f8fe0c7ad901

December 8, 2021

Umicore and Volkswagen AG to create European EV battery materials Joint Venture

Umicore and Volkswagen AG to create European EV battery materials Joint Venture

Umicore and Volkswagen AG plan to establish a joint venture to build up precursor and cathode material production capacities in Europe to supply Volkswagen AG’s European battery cell production, making a considerable contribution to the region’s transition towards cleaner mobility.

This partnership will be the first of its kind in the European automotive market. It will help achieve the ambitions of the European Green Deal, including the establishment of a sustainable battery supply chain, and is a strong signal for the ongoing roll-out of innovative battery cell technologies and capabilities in the region.

The intention is to gradually ramp up the JV’s precursor and cathode material production capacity. This would start in 2025 with an initial annual production of 20 GWh for Volkswagen AG’s plant in Salzgitter, Germany, and should grow to an annual production capacity of up to 160 GWh by the end of the decade. This compares to an annual production capacity capable of powering about 2.2 million full electric vehicles (EVs).

At the same time, next to the intended JV, Umicore will continue to steadfastly develop its technological and production capabilities to serve other customers and regions.

“As a leader in clean mobility materials, we are committed to support our automotive and battery-cell customers with their electrification strategies. We are very pleased to partner with Volkswagen in this unique joint venture and will bring in our long-standing and proven expertise in battery materials, as well as our strong commitment and solutions to today’s sustainability challenges,” said Mathias Miedreich, CEO of Umicore. “The complementarity of our extensive technology, innovation and industrial knowhow, and shared sustainability convictions will provide a strong framework for the JV and will give us a considerable first-mover advantage.”

Thomas Schmall, Member of the Board of Management of Volkswagen Group for Technology and CEO of Volkswagen Group Components: “Volkswagen is implementing its battery strategy very consistently and at a high pace. The Volkswagen unified cell must be at the forefront of performance, costs and sustainability right from the start. Teaming up with Umicore enables us to establish a state-of-the-art supply chain in Europe as we share common values such as responsible sourcing of raw materials, as well as closed-loop thinking.”

The partnership’s significant scale will provide secure and cost-competitive supplies of innovative, sustainably sourced and tailored high-performance cathode materials for Volkswagen AG’s ambitious unified cell strategy. It provides Umicore secured access to an important part of the European demand for EV cathode materials, which will unlock significant economies of scale and represents a major leap forward in the further roll-out of its strategy to be a global leader in clean mobility materials.

In the context of the JV, Umicore and Volkswagen AG will furthermore collaborate on the sustainable and responsible sourcing of raw materials, which is a strong area of expertise of Umicore. Both parties aim to include at a later stage, elements of refining and battery recycling into the scope of the JV.

The planned JV is subject to final agreements and customary conditions, including regulatory approvals.

Short-term earnings in battery materials hampered by lower volumes in combination with higher fixed costs related to recent and ongoing expansions

The JV’s portfolio offering will cover next-generation technologies, including a very large portion of high-nickel chemistries. The latter have become faster than anticipated the car industry’s preferred solution to enable higher energy density and longer driving ranges and this is consequently significantly impacting demand for mid-nickel chemistries. Umicore successfully fast-tracked innovation on the next generation higher nickel product and process capabilities and now offers industry-leading high nickel cathode material technology, as also witnessed by today’s announcement.

In the short-term, Umicore is still largely exposed to mid-nickel NMC platforms. Customer demand projections for certain of these qualified mid-nickel platforms are being scaled back to their minimum offtake commitments, resulting in lower volume forecasts for 2022 and 2023, beyond the negative volume impacts from semiconductor shortages. Consequently, Umicore now expects growth in its cathode material sales volumes in 2022 and 2023 to be less than previously anticipated and to be below the anticipated global market growth. These scaled-down short-term volume expectations, together with the need to increase fixed costs to prepare for the expected steep mid-term growth, such as higher R&D expenses and costs related to the recent and ongoing expansions, are likely to result in lower-than-expected earnings growth in Rechargeable Battery Materials in 2022 and 2023. Hence, assuming that Cobalt & Specialty Materials will not repeat the exceptionally strong 2021 performance, the earnings of the Energy & Surface Technologies segment are not expected to show a significant uplift over that period.

Strong mid-term earnings growth comforted

Umicore’s innovation pipeline and strong track record in cathode material technologies, alongside with its flexible production system have allowed to act with agility to the rapidly evolving customer voice. The intention to set up this JV with Volkswagen AG contributes further strength to the Group’s competitive positioning. Its strong technology roadmap, synced with customers’ requirements, puts Umicore in a unique position to disproportionally benefit in the mid-term from the extremely high anticipated growth in EV battery materials. This will significantly boost operating leverage through economies of scale and will allow Umicore to achieve attractive margins and returns in its fast-growing battery materials activity.

Conference call and webcast

A conference call and webcast will be hosted by Mathias Miedreich, CEO, and Filip Platteeuw, CFO, Wednesday December 8 at 9:00 am CET.

More information on: https://umicore.com/dec_2021_webcast

For more information

Investor Relations

Saskia Dheedene +32 2 227 72 21 saskia.dheedene@umicore.com

Eva Behaeghe +32 2 227 70 68 eva.behaeghe@umicore.com

Media Relations

Marjolein Scheers +32 2 227 71 47 marjolein.scheers@umicore.com

Caroline Jacobs +32 2 227 71 47 caroline.jacobs@umicore.com

Umicore profile

Umicore is a global materials technology and recycling group. It focuses on application areas where its expertise in materials science, chemistry and metallurgy makes a real difference. Its activities are organised in three business groups: Catalysis, Energy & Surface Technologies and Recycling. Each business group is divided into market-focused business units offering materials and solutions that are at the cutting edge of new technological developments and essential to everyday life. Umicore generates the majority of its revenues and dedicates most of its R&D efforts to clean mobility materials and recycling.

Umicore’s overriding goal of sustainable value creation is based on an ambition to develop, produce and recycle materials in a way that fulfils its mission: materials for a better life. Umicore’s industrial and commercial operations as well as R&D activities are located across the world to best serve its global customer base.

The Group generated revenues (excluding metal) of € 2.1 billion (turnover of € 12.7 billion) in the first half of 2021 and currently employs just below 11,000 people.

December 8, 2021

Cobwebs Technologies Wins Globee® in the Annual 2021 Disruptor Company Awards

Cobwebs Technologies Named Winner in the Annual 2021 Disruptor Company Awards

Cobwebs Technologies – Globee award

NEW YORK, Dec. 08, 2021 (GLOBE NEWSWIRE) — Cobwebs Technologies announced today that The Globee® Awards, organizers of the world’s premier business awards programs and business ranking lists, has named Cobwebs’ Web Investigation Platform, a winner in the Annual 2021 Disruptor Company Awards. These prestigious global awards recognize disruptive technologies and innovative solutions that are transforming consumer experiences everywhere.

Cobwebs’ powerful web intelligence solution monitors online activity, collecting and analyzing data of endless digital channels – from the open, deep, and dark web, to mobile and social. Our exclusive deep and dark web monitoring technology extracts targeted intelligence from the web’s big data using the latest machine learning algorithms, automatically generating critical insights.

“We are proud to be recognized as an industry player whose Web Investigation Platform has been named a winner by the Globee Awards,” said Udi Levy, CEO, Cobwebs Technologies. “Behind this distinguished success is our product innovations and relentless drive to stay customer-focused. We believe this recognition from Globee Awards further validates our commitment to our customers.”

Judges from around the world representing a wide spectrum of industry experts participated in the judging process.

“Disruptive technologies and solutions are transforming consumer experiences everywhere while consumer and end-user needs are continuously evolving,” said San Madan, co-President of Globee Awards. “Legacy systems are not always fast enough to accept and respond to such needs.”

Disruptors are companies that have the potential and competence to displace existing solutions, companies, and even entire industries.

To be eligible to participate, a business must be a privately owned company that’s operating for profit, must be independently owned and not a subsidiary, and can be located anywhere in the world.

Disruptors are highly persistent, mostly beginning from scratch without the constraints of traditionally accepted processes or business models. They use technology and modern tools to achieve end results. Disruptors do things differently and are not hindered by existing ways of industry stalwarts. They are ready to take on an enormous challenge and find solutions for the biggest pain points customers experience.

About Cobwebs Technologies

Cobwebs Technologies is a worldwide leader in web intelligence. Our innovative solutions are tailored to the operational needs of national security agencies and the private sector, identifying threats with just one click.

Cobwebs solutions were designed by our intelligence and security experts as vital tools for the collection and analysis of data from all web layers: social media, open, deep, and dark web. Our web intelligence platform monitors these vast sources of data to reveal hidden leads and generate insights.
Our exclusive technology extracts targeted intelligence from big data using the latest machine learning algorithms, automatically generating intelligent insights.

For further details contact us @: info@cobwebs.com

This content was issued through the press release distribution service at Newswire.com.

Attachment

Cobwebs Technologies – Globee award

December 8, 2021

Nikkiso Cryogenic Services Announces Soletec Group (Qatar) As Authorized Representative & Service Partner

TEMECULA, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a subsidiary of Nikkiso Co., Ltd (Japan), is proud to announce that Soletec Group (Soletec) has become the Authorized Representative and Service Partner for Nikkiso Cryogenic Services (NCS) in Qatar.

With the growth of the Middle East market, this association has allowed the Group to extend their regional presence for the industrial gases, hydrogen, marine, natural gas processing and petrochemical industries. Since July 1, 2021, Soletec has been able to provide aftermarket service and support to the local customers and shipyards with service and support of pumps, turbo expanders and process plants, including packaging, repairs, spare parts and field service.

Based in Doha, Qatar, Soletec will support Nikkiso Clean Energy & Industrial Gases Group in establishing a strong long service operations to support all our existing customers.

“The newly formed partnership with Nikkiso Clean Energy & Industrial Gases Group and Soletec gives us a stronger presence in Qatar and strengthens our ability to better serve our key customers,” according to Jim Estes, President, Nikkiso Cryogenic Services. “I am looking forward to continuing to provide Nikkiso’s customers top quality service and support by eliminating costly downtime to their operations and processes.”

Soletec Group has been providing services to the Oil and Gas industry for more than 50 years. As a leading provider of design, engineering and production services across the upstream, midstream and downstream supply chain, Soletec Group has established long-term relationships with some of the world’s most important oil and gas companies.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture engineered cryogenic gas processing equipment and small-scale process plants for the liquefied natural gas (LNG), well services and industrial gas industries. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information, please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com